At the California Neuromodulation Institute, we are dedicated to your health and well-being. We have diverse interventions available, including transcranial magnetic stimulation (TMS), conventional psychopharmacology, ketamine, and self-guided psychotherapy. This mix of traditional and innovative treatments is proven and safe, and makes up our unique, patient-centric approach.
Innovative, Patient-Centered Psychiatric Care
Transcranial Magnetic Stimulation
Ketamine is an old medication with a new use for treatment-resistant depression. Those who gain benefit may often respond quickly, and it can serve as an alternative to TMS. We can discuss with you how TMS and ketamine treatments compare.
Participate in the Coronavirus Distress Inventory Survey
Michael Minzenberg, MD
“I have been practicing psychiatry for 25 years. My vision for the California Neuromodulation Institute is a patient-centered practice that is both evidence-based and innovative, and integrates diverse biomedical and psychosocial interventions to achieve optimal mental health outcomes.”
NEWS & RESEARCH
The California Neuromodulation Institute seeks outstanding psychiatric nurse practitioners to join an innovative, growing private practice in the San Francisco East Bay region. We are primarily dedicated to patients with depression and anxiety conditions. Our program...
We are thrilled to announce our new practice in San Ramon! On April 18 2022 we opened a second office in the Bishop Ranch development in San Ramon. This is a smalleroffice for now, dedicated to expert medication management for adults with depression or...
So, what exactly is a Migraine? Migraine is a disorder where individuals suffer from recurring, severe and often debilitating headaches. Classic migraine is unlike other headaches, and is typically experienced on one side of the head (from which the name is derived),...
Transcranial magnetic stimulation (TMS) is a safe and effective therapeutic modality for a rapidly expanding range of neuropsychiatric indications. Among psychiatric conditions, it is presently approved by the US Food and Drug Administration for treatment-resistant...
The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment
Association of Anticholinergic Load With Impairment of Complex Attention and Memory in Schizophrenia
Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy
Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder
Get In Touch
895 Moraga Road, Suite 15 Lafayette, CA 94549
Monday 3:30-6:30 PM
Tuesday 2:00-6:30 PM
Wednesday 3:30-6:30 PM
Thursday 1:30-6:30 PM
Friday 1:30-6:30 PM
Saturday 10:00 AM to 2:00 PM